Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Stephen D. Nimer, MD

    ... patients with myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML), multiple myeloma, and lymphoma for over three ...

    Bio last updated 03/11/2016 - 1:41pm.

  2. Gene Mutations in Aplastic Anemia

    ... to 15% of patients with aplastic anemia develop MDS or acute myelogenous leukemia (AML). The authors analyzed DNA from 439 patients ...

    Research Review last updated 05/02/2016 - 9:15am.

  3. Spectrum of Genetic Alterations in Acquired Aplastic Anemia

    ... , myelodysplastic syndromes (MDS), or acute myelogenous leukemia (AML). The relationships between these diseases ...

    Research Review last updated 05/02/2016 - 9:20am.

  4. Spectrum of Genetic Alterations in Acquired Aplastic Anemia

    ... , myelodysplastic syndromes (MDS), or acute myelogenous leukemia (AML). The relationships between these diseases ...

    Research Review last updated 05/02/2016 - 9:19am.

  5. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... allogeneic stem cell transplant : 5.1.2.1 Chronic myelogenous leukemia (CML): Subjects under the age of 21 in chronic phase OR ... in accelerated phase or blast transformation. OR 5.1.2.2 Acute lymphoblastic leukemia (ALL): any of these categories: Adult ALL ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  6. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... suitably matched related or unrelated donor . Acute myelogenous leukemia (AML): Complete first remission (CR1) at high risk ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  7. Clinical Trials Report for December 2014

    ... Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) The goal of ...

    Page last updated 11/25/2014 - 3:33pm.

  8. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    ... puberty) and 40 years of age. These patients must have acute myelogenous leukemia , acute lymphocytic leukemia, or ...

    Clinical Trial last updated 04/28/2016 - 11:14am.

  9. Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

    ... see how well they work in treating patients with high-risk acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelogenous leukemia (CML) that has returned after a period of improvement ...

    Clinical Trial last updated 04/29/2016 - 10:34am.

  10. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... or transfusion dependence, RAEB-1 and RAEB-2 and Acute myelogenous leukemia (AML) evolved from MDS, who are not eligible for ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.